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3. Progress Report. (See Instructions) 
la. "Low Pressure Tritiation of Proteins," M. O. Lively, T. F. Moran and J. C. Powers, 
J. Biol. Chem. 254, 262-264 (1979). 
lb. "Tritium Labeling of Thermolysin, Elastase and Ribonuclease by Exposure to Tritium 
Gas at Low Pressure", M. O. Lively, G. A. Bush, B. P. Mathur, T. F, Moran and 
J. C. Powers, Submitted to Arch. Biochem. Biophys. 
2. Dr. Norio Yoshida (postdoctoral associate) will be leaving the project in March. 
We are currently trying to find a research scientist to replace him. There are 
no changes in effort. 
3. Progress Report - Tritium Labelling Using Ion Beam Techniques. A clean and fast 
method of incorporating tritium into molecules using ion beams has been further developed 
and tested during the past year. This ion beam method is a very general and non-
destructive approach to the production of tritiated molecules. The apparatus consists of 
a high vacuum stainless steel system composed of a main reaction chamber, T2 storage 
vessels T -
2 
 recovery system, miniature quadrupole mass spectrometer for situ gas analysis, 
electron beam production device, ion beam acceleration and focusing system, sample 
holder and irradiation system, pressure measurement devices (Barytron Manometric, ion 
gauge and thermocouple), liquid nitrogen traps, fast diffusion pump and roughing pumps. 
Various parts of this apparatus and methods have been improved during this time so as 
to hold to stringent quality control requirements. The small mass spectrometer has 
enabled us to quantitatively sample the I reactant gas for purity as well as sample the 
residual background gases during the pump
2
down time and during the irradiation process. 
With this spectrometer we have been able to eliminate all variables due to gas 
evolution from chamber walls, water and gas desorption from lyophilized samples under 
high vacuum conditions and thus improve the efficiency of the tritiation processes. 
Tritium ions are produced by electron impact ionization of T gas which is leaked 
into the ion source from a T 2 storage vessel using a Granville-Ph il ips precision needle 
valve. The path of the electrons has been carefully controlled so that electrons do 
not interact with the solid sample to be tritiated and the electrons cannot damage the 
sample. The ions are drawn into a grid assembly for focussing and further acceleration. 
The kinetic energies of the reactant tritium ions are controlled by voltages on the 
various grids. These fast reactant ions are focussed on the entire surface area of 
the sample. By analyzing the tritiated sample, section by section, we find that the 
samples are uniformly tritiated over the entire area exposed to the reactant ion beam. 
The incorporation has been examined as a function of sample thickness and sample weight. 
We find that provided the ion beam kinetic energy is sufficiently high to penetrate the 
sample, the exchange process occurs uniformly 'iroughout the macroscopic sample. The 
time required for achieving given sample radioa :ivities has been shortened during the 
past year. For example, the initial requirement of 62 hours exposure time has been 
cut to 30 minutes and sample activity levels have been significantly increased. 
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Progress Report (Continued) GM 25181-03 
The table listed below outlines the compounds which have been tritiated to date 
and the specific radioactivities which have been obtained. 
Small Molecules  
desmosine - an amino acid found in elastin 	 2.4 Ci/mole 
nicotine sulfate 	 2.2 
benzyl hydroxylamine tosylate salt 	 67 
octanoic acid sodium salt 	 0.8 
phenyl propylamine hydrochloride salt 	 0.5 
leupeptin, a protease inhibitor isolated from 
actinomycetes (acetyl-leucyl-leucyl-argininal) 	 27 
Proteins  
thermolysin 	 ca300 
elastase, porcine 	 280 
ribonuclease, bovine 53 
soybean trypsin inhibitor 	 859 





-antitrypsin) 	 415 
In no case has any decomposition of the sample been observed. 
After tritiation, the small molecules were worked up by dissolving the sample 
in water and then removing the water by evaporation or lyophilization. Repetition Of 
this process for four or five times, completely removed exchanged tritium. The 
specific activities which we have obtained thus far with small molecules are low, but 
in the useful range for many types of experiments. In each case, the purity of the 
products were checked by thin layer or high pressure liquid chromatography. No 
decomposition products were detected. We are currently carrying out radioautography 
experiments to check for the presence of low amounts of radioactive byproducts. 
With proteins, much higher specific activities have been obtained. However, 
the removal of exchangable tritium is more difficult. A representative workup 




After tritiation 6833 
After 1st dialysis 6644 
After 2nd dialysis 3364 
DEAE -cellulose column 937 
Sephadex G-100 column 857 










Progress Report (Continued) 	 GM 25181-03 
In all cases studied thus far, one or two column steps have been required to 
remove most of the readily exchangable tritium. The recoveries of protein are 
typically in the range of 70-80%. Losses seem to be due to some denaturation during 
handling. In all cases the protein retains 100% biological activity and shows only 
one band on gel electrophoresis. 
Research Goals. We are making steady progress in achieving higher tritium levels 
in various types of molecules and we plan to continue exploring all routes to efficient 
tritium labelling using our method- The influence of such factors as ion kinetic 
energy neutralization of ion space charge on solid samples, and reactant ion internal 
energy will be examined in detail with a view to maximizing tritium incorporation. 
Thus far we have utilized only small amounts of tritium (300 m Ci) in our experiments. 
We intend to increase the amount of tritium utilized and the extent of exposure to 
the beam until a point is reached where sample decomposition begins to occur. 
Furthermore, we are giving to begin to locate the sites at which tritium exchange 
occurs in order to understand the mechanism of the exchange process. 
Significance. The potential usefulness of our tritiation procedure is almost 
limitless. We have thus far been able to tritiate every molecule that we have in-
vestigated. These include proteins from human sources which are difficult or impossible 
to label otherwise. Minimal decomposition has been observed and the products are 
biologically active. Tritiated molecules can be used in numerous ways in research 
and therapy. We have already tritiated molecules for four other investigators and 
we believe the demand for tritiated molecules is going to be quite high once the 
scientific community becomes aware of our method. 
The undersigned agrees to accept responsibility for the scientific and 
technical conduct of the project and for provision of required progress reports 
if a grant is awarded as the result of this application. 
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